Literature DB >> 34260270

Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.

Cory J Knudson1, Maria Férez1, Pedro Alves-Peixoto1,2,3, Dan A Erkes1, Carolina R Melo-Silva1, Lingjuan Tang1, Christopher M Snyder1, Luis J Sigal1.   

Abstract

Cytotoxic CD4 T lymphocytes (CD4-CTL) are important in antiviral immunity. For example, we have previously shown that in mice, CD4-CTL are important to control ectromelia virus (ECTV) infection. How viral infections induce CD4-CTL responses remains incompletely understood. We demonstrate here that not only ECTV but also vaccinia virus and lymphocytic choriomeningitis virus induce CD4-CTL, though the response to ECTV is stronger. Using ECTV, we also demonstrate that in contrast to CD8-CTL, CD4-CTL differentiation requires constant virus replication and ceases once the virus is controlled. We also show that major histocompatibility complex class II molecules on CD11c+ cells are required for CD4-CTL differentiation and for mousepox resistance. Transcriptional analysis indicated that antiviral CD4-CTL and noncytolytic T helper 1 (Th1) CD4 T cells have similar transcriptional profiles, suggesting that CD4-CTL are terminally differentiated classical Th1 cells. Interestingly, CD4-CTL and classical Th1 cells expressed similar mRNA levels of the transcription factors ThPOK and GATA-3, necessary for CD4 T cell linage commitment, and Runx3, required for CD8 T cell development and effector function. However, at the protein level, CD4-CTL had higher levels of the three transcription factors, suggesting that further posttranscriptional regulation is required for CD4-CTL differentiation. Finally, CRISPR/Cas9-mediated deletion of Runx3 in CD4 T cells inhibited CD4-CTL but not classical Th1 cell differentiation in response to ECTV infection. These results further our understanding of the mechanisms of CD4-CTL differentiation during viral infection and the role of posttranscriptionally regulated Runx3 in this process. IMPORTANCE While it is well established that cytotoxic CD4 T cells (CD4-CTLs) directly contribute to viral clearance, it remains unclear how CD4-CTL are induced. We now show that CD4-CTLs require sustained antigen presentation and are induced by CD11c-expressing antigen-presenting cells. Moreover, we show that CD4-CTLs are derived from the terminal differentiation of classical T helper 1 (Th1) subset of CD4 cells. Compared to Th1 cells, CD4-CTLs upregulate protein levels of the transcription factors ThPOK, Runx3, and GATA-3 posttranscriptionally. Deletion of Runx3 in differentiated CD4 T cells prevents induction of CD4-CTLs but not classical Th1 cells. These results advance our knowledge of how CD4-CTLs are induced during viral infection.

Entities:  

Keywords:  CD4 T cells; Runx3; cytotoxic CD4 T cells; ectromelia virus; immune mechanisms; immune response

Mesh:

Substances:

Year:  2021        PMID: 34260270      PMCID: PMC8428409          DOI: 10.1128/JVI.00566-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection.

Authors:  Min Fang; Nicholas A Siciliano; Adam R Hersperger; Felicia Roscoe; Angela Hu; Xueying Ma; Ahamed R Shamsedeen; Laurence C Eisenlohr; Luis J Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection.

Authors:  Kathleen A Stuller; Emilio Flaño
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

3.  The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation.

Authors:  Scott M Gordon; Julie Chaix; Levi J Rupp; Junmin Wu; Sharline Madera; Joseph C Sun; Tullia Lindsten; Steven L Reiner
Journal:  Immunity       Date:  2012-01-18       Impact factor: 31.745

4.  Transcription factor T-bet regulates intraepithelial lymphocyte functional maturation.

Authors:  Bernardo S Reis; David P Hoytema van Konijnenburg; Sergei I Grivennikov; Daniel Mucida
Journal:  Immunity       Date:  2014-08-21       Impact factor: 31.745

5.  A 19-kDa protein belonging to a new family is expressed in the Golgi apparatus of neural cells.

Authors:  D Sabéran-Djoneidi; I Marey-Semper; R Picart; J M Studler; C Tougard; J Glowinski; M Lévi-Strauss
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

6.  Suppression of Tcf1 by Inflammatory Cytokines Facilitates Effector CD8 T Cell Differentiation.

Authors:  Maxime Danilo; Vijaykumar Chennupati; Joana Gomes Silva; Stefanie Siegert; Werner Held
Journal:  Cell Rep       Date:  2018-02-20       Impact factor: 9.423

7.  Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche.

Authors:  Arnob Banerjee; Scott M Gordon; Andrew M Intlekofer; Michael A Paley; Erin C Mooney; Tulia Lindsten; E John Wherry; Steven L Reiner
Journal:  J Immunol       Date:  2010-10-08       Impact factor: 5.422

8.  Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.

Authors:  Nicholas A Siciliano; Adam R Hersperger; Aimee M Lacuanan; Ren-Huan Xu; John Sidney; Alessandro Sette; Luis J Sigal; Laurence C Eisenlohr
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

9.  Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking.

Authors:  Min Fang; Felicia Roscoe; Luis J Sigal
Journal:  J Exp Med       Date:  2010-09-27       Impact factor: 14.307

10.  The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.

Authors:  Ren-Huan Xu; Matthew Cohen; Yong Tang; Eric Lazear; J Charles Whitbeck; Roselyn J Eisenberg; Gary H Cohen; Luis J Sigal
Journal:  J Exp Med       Date:  2008-04-07       Impact factor: 14.307

View more
  1 in total

1.  Epigenetic Reprogramming Leads to Downregulation of CD4 and Functional Changes in African Green Monkey Memory CD4+ T Cells.

Authors:  Andrew R Rahmberg; Tovah E Markowitz; Joseph C Mudd; Vanessa Hirsch; Jason M Brenchley
Journal:  J Immunol       Date:  2022-06-24       Impact factor: 5.426

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.